MDVAX vs. ARINX

Last updated Jun 3, 2026

MDVAX (MassMutual Diversified Bond Fund) and ARINX (Archer Income Fund) are both Intermediate Core-Plus Bond funds. Over the past 10 years, MDVAX returned 2.22%/yr vs 2.21%/yr for ARINX. A 0.68 correlation means they provide meaningful diversification when combined. MDVAX charges 1.07%/yr vs 0.98%/yr for ARINX.

Performance

MDVAX vs. ARINX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MassMutual Diversified Bond Fund (MDVAX) and Archer Income Fund (ARINX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MDVAX achieves a 2.59% return, which is significantly higher than ARINX's 0.59% return. Both investments have delivered pretty close results over the past 10 years, with MDVAX having a 2.22% annualized return and ARINX not far behind at 2.21%.

MDVAX

• 1D: 0.00%
• 1M: 0.84%
• YTD: 2.59%
• 6M: 2.82%
• 1Y: 8.43%
• 3Y*: 5.96%
• 5Y*: 0.36%
• 10Y*: 2.22%

ARINX

• 1D: -0.06%
• 1M: 0.07%
• YTD: 0.59%
• 6M: 0.69%
• 1Y: 4.02%
• 3Y*: 4.73%
• 5Y*: 1.35%
• 10Y*: 2.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MDVAX vs. ARINX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MDVAX MassMutual Diversified Bond Fund	2.59%	8.40%	2.47%	5.81%	-17.01%	1.95%	8.08%	10.12%	-1.55%	4.52%
ARINX Archer Income Fund	0.59%	4.42%	4.90%	3.99%	-6.84%	1.52%	4.29%	6.19%	0.35%	3.18%

Correlation

The correlation between MDVAX and ARINX is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.78
Correlation (3Y) Calculated over the trailing 3-year period	0.81
Correlation (5Y) Calculated over the trailing 5-year period	0.77
Correlation (10Y) Calculated over the trailing 10-year period	0.73
Correlation (All Time) Calculated using the full available price history since Mar 10, 2011	0.68

The correlation between MDVAX and ARINX shifts across timeframes, from 0.68 (all time) to 0.81 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

MDVAX vs. ARINX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDVAX

MDVAX Risk / Return Rank: 82
MDVAX Sharpe Ratio Rank: 74
MDVAX Sortino Ratio Rank: 86
MDVAX Omega Ratio Rank: 77
MDVAX Calmar Ratio Rank: 85
MDVAX Martin Ratio Rank: 87

ARINX

ARINX Risk / Return Rank: 55
ARINX Sharpe Ratio Rank: 57
ARINX Sortino Ratio Rank: 64
ARINX Omega Ratio Rank: 68
ARINX Calmar Ratio Rank: 44
ARINX Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDVAX vs. ARINX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MassMutual Diversified Bond Fund (MDVAX) and Archer Income Fund (ARINX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MDVAX	ARINX	Difference
Sharpe ratio Return per unit of total volatility	2.49	2.22	+0.27
Sortino ratio Return per unit of downside risk	4.11	3.36	+0.75
Omega ratio Gain probability vs. loss probability	1.50	1.46	+0.04
Calmar ratio Return relative to maximum drawdown	3.97	2.56	+1.41
Martin ratio Return relative to average drawdown	16.74	8.98	+7.76
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MDVAX vs. ARINX - Sharpe Ratio Comparison

The current MDVAX Sharpe Ratio is 2.49, which is comparable to the ARINX Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of MDVAX and ARINX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MDVAX	ARINX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.49	2.22	+0.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.06	0.66	-0.60
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.42	1.12	-0.70
Sharpe Ratio (All Time) Calculated using the full available price history	0.71	0.53	+0.18

Drawdowns

MDVAX vs. ARINX - Drawdown Comparison

The maximum MDVAX drawdown since its inception was -23.02%, which is greater than ARINX's maximum drawdown of -9.38%. Use the drawdown chart below to compare losses from any high point for MDVAX and ARINX.

Drawdown Indicators

	MDVAX	ARINX	Difference
Max Drawdown Largest peak-to-trough decline	-23.02%	-9.38%	-13.64%
Max Drawdown (1Y) Largest decline over 1 year	-2.21%	-1.57%	-0.64%
Max Drawdown (3Y) Largest decline over 3 years	-5.44%	-1.57%	-3.87%
Max Drawdown (5Y) Largest decline over 5 years	-23.02%	-9.38%	-13.64%
Max Drawdown (10Y) Largest decline over 10 years	-23.02%	-9.38%	-13.64%
Current Drawdown Current decline from peak	-3.38%	-0.63%	-2.75%
Average Drawdown Average peak-to-trough decline	-3.47%	-1.73%	-1.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.52%	0.45%	+0.07%

Volatility

MDVAX vs. ARINX - Volatility Comparison

MassMutual Diversified Bond Fund (MDVAX) has a higher volatility of 0.95% compared to Archer Income Fund (ARINX) at 0.80%. This indicates that MDVAX's price experiences larger fluctuations and is considered to be riskier than ARINX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MDVAX	ARINX	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.95%	0.80%	+0.15%
Volatility (6M) Calculated over the trailing 6-month period	2.19%	1.46%	+0.73%
Volatility (1Y) Calculated over the trailing 1-year period	3.30%	1.79%	+1.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	6.46%	2.06%	+4.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	5.27%	1.97%	+3.30%

MDVAX vs. ARINX - Expense Ratio Comparison

MDVAX has a 1.07% expense ratio, which is higher than ARINX's 0.98% expense ratio.

Dividends

MDVAX vs. ARINX - Dividend Comparison

MDVAX's dividend yield for the trailing twelve months is around 3.99%, more than ARINX's 3.58% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARINX Archer Income Fund	3.58%	2.72%	3.77%	3.15%	2.72%	2.56%	2.66%	2.69%	2.84%	2.94%	2.84%	2.79%
MDVAX MassMutual Diversified Bond Fund	3.99%	3.91%	2.45%	4.87%	3.76%	4.06%	7.20%	2.90%	2.86%	2.64%	2.11%	0.53%

Frequently Asked Questions

Can I hold both MDVAX and ARINX in my portfolio?

MDVAX and ARINX have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MDVAX or ARINX?

MDVAX has higher volatility (0.95%) compared to ARINX (0.80%). In terms of maximum drawdown, MDVAX dropped -23.02% vs ARINX's -9.38%.

Which has better risk-adjusted returns?

MDVAX currently has the higher Sharpe Ratio (2.49 vs 2.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.